HUMA - Humacyte Inc
IEX Last Trade
6.05
-0.100 -1.653%
Share volume: 4,186,511
Last Updated: Fri 30 Aug 2024 09:59:58 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$6.15
-0.10
-1.63%
Summary score
13%
Profitability
0%
Dept financing
14%
Liquidity
75%
Performance
11%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2019 - 30-Jun-2023
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-16.66%
Return on assets
-10.75%
Return on sales
-28850.6%
Return on invested capital
-42.05%
Total debt ratio
52.03%
Debt ratio change over timeo
-2.06%
Current Ratio
11.8%
Quick Ratio
11.8%
Cash Position Ratio
11.54%
Short-term ratios 30-Jun-2022 - 30-Jun-2023
The data are presented for the financials results of the quarters of the last year.
Return on equity
-26.7%
Return on assets
-12.19%
Return on sales
-75787.1%
Return on invested capital
-73.72%
Total debt ratio
52.3%
Debt ratio change over timeo
-2.62%
Current Ratio
8.47%
Quick Ratio
8.47%
Cash Position Ratio
8.25%
Last quarter ratios 30-Jun-2023
The data are presented for the financials results of the last quarter.
Return on equity
-37.15%
Return on assets
-15.9%
Return on sales
0%
Return on invested capital
-62.8%
Total debt ratio
63.64%
Debt ratio change over time
-2.43%
Current Ratio
10.59%
Quick Ratio
10.59%
Cash Position Ratio
10.06%
Performance ratios (change over 4 years) 30-Jun-2019 - 30-Jun-2023
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-54.07%
Return on assets
-75.33%
Return on sales
204182%
Return on invested capital
37.93%
Total debt ratio
-206.11%
Debt ratio change over time
-2.06%
Current Ratio
-20.86%
Quick Ratio
-20.86%
Cash Position Ratio
-20.38%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | HUMA | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -16.66% | 5.24% | 35.86% | 7.9% |
| Return on assets | -10.75% | 3.12% | 3.56% | 5.95% |
| Return on sales | -28850.6% | 31.5% | 36.15% | 41.33% |
| Return on invested capital | -42.05% | 4.08% | 6.32% | 20.63% |
| Profitability | 0% | 41% | 69% | 81% |
| Total debt ratio | 52.03% | 93.78% | 88.68% | 27.19% |
| Debt ratio change over time | -2.06% | 291.08% | 15.01% | 0.97% |
| Dept financing | 14% | 50% | 25% | 7% |
| Current Ratio | 8.47% | 0.94% | 2.25% | 5.33% |
| Quick Ratio | 8.47% | 0.82% | 1.93% | 4.53% |
| Cash Position Ratio | 8.25% | 0.3% | 1.4% | 2.67% |
| Liquididy | 75% | 6% | 9% | 20% |
| Short-term ratios | HUMA | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -26.7% | 14.06% | 44.07% | 4.73% |
| Return on assets | -12.19% | 3.29% | 3.18% | 3.77% |
| Return on sales | -75787.1% | 32% | 34.58% | 34.56% |
| Return on invested capital | -73.72% | 2.77% | 7.32% | 10.76% |
| Profitability | 0% | 59% | 88% | 78% |
| Total debt ratio | 52.3% | 89.22% | 93.78% | 22.11% |
| Debt ratio change over time | -2.62% | 98.45% | 12.55% | 1.14% |
| Dept financing | 14% | 49% | 28% | 6% |
| Current Ratio | 8.47% | 0.94% | 2.25% | 5.33% |
| Quick Ratio | 8.47% | 0.82% | 1.93% | 4.53% |
| Cash Position Ratio | 8.25% | 0.3% | 1.4% | 2.67% |
| Liquididy | 75% | 6% | 17% | 37% |